BRIEF published on 09/18/2024 at 07:35, 19 hours 38 minutes ago Sensorion annonce ses résultats financiers et ses avancées cliniques pour le premier semestre 2024 Essais Cliniques Thérapie Génique Résultats Financiers 2024 Sensorion Thérapies Pour La Perte Auditive
BRIEF published on 09/18/2024 at 07:35, 19 hours 38 minutes ago Sensorion Reports First Half 2024 Financial Results and Clinical Advances Clinical Trials Gene Therapy 2024 Financial Results Sensorion Hearing Loss Therapies
PRESS RELEASE published on 09/18/2024 at 07:30, 19 hours 43 minutes ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel Sensorion publie ses résultats du premier semestre 2024 et fait le point sur ses activités. Premières données cliniques de SENS-501 et SENS-401 au Congrès Mondial d'Audiologie Résultats Premier Semestre Audiologie Sensorion Clinique
PRESS RELEASE published on 09/18/2024 at 07:30, 19 hours 43 minutes ago Half yearly financial reports and audit reports/limited reviews / Half yearly financial report Sensorion reports 2024 first half results including progress on SENS-501 and SENS-401 programs. Cash position strong at €87m. Future milestones and financial highlights outlined Sensorion Hearing Loss SENS-401 SENS-501 2024 Results
BRIEF published on 09/12/2024 at 07:35, 6 days 19 hours ago Sensorion présentera au 59e atelier sur la biologie de l'oreille interne Conference Sensorion Perte Auditive Biologie De L'oreille Interne Protéomique
BRIEF published on 09/12/2024 at 07:35, 6 days 19 hours ago Sensorion to Present at 59th Inner Ear Biology Workshop Conference Sensorion Hearing Loss Inner Ear Biology Proteomics
PRESS RELEASE published on 09/12/2024 at 07:30, 6 days 19 hours ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la 59ème conférence annuelle Inner Ear Biology Workshop pour présenter des résultats sur SENS-401 et d'autres thérapies auditives innovantes Sensorion Thérapies Auditives SENS-401 59ème Conférence Biologie Oreille Interne
PRESS RELEASE published on 09/12/2024 at 07:30, 6 days 19 hours ago Inside Information / Other news releases Sensorion announces participation in the 59th Annual Inner Ear Biology Workshop in Warsaw, Poland. Presentation on SENS-401 and gene therapy programs Gene Therapy Sensorion Hearing Loss SENS-401 Inner Ear Biology Workshop
BRIEF published on 09/02/2024 at 07:35, 16 days 19 hours ago Sensorion at the World Congress of Audiology 2024 in Paris Gene Therapy Sensorion Hearing Loss World Congress Of Audiology Medical Symposium
BRIEF published on 09/02/2024 at 07:35, 16 days 19 hours ago Sensorion au Congrès Mondial d’Audiologie 2024 à Paris Thérapie Génique Sensorion Perte Auditive Congrès Mondial D’Audiologie Symposium Médical
Published on 09/18/2024 at 23:10, 4 hours 3 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 4 hours 13 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 58 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 6 hours 13 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 10 hours 43 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 8 hours 2 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 8 hours 28 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 8 hours 41 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 9 hours ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 9 hours 51 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 8 hours 27 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 8 hours 27 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 9 hours 33 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.